07:33 AM EDT, 07/21/2025 (MT Newswires) -- Protalix BioTherapeutics ( PLX ) said Monday it has appointed Gilad Mamlok as its chief financial officer, effective Aug. 24.

Mamlok succeeds Eyal Rubin, who will remain available to Protalix BioTherapeutics ( PLX ) as needed until October to support a smooth transition, the company said.

Mamlok was previously TytoCare's CFO, Protalix BioTherapeutics ( PLX ) added.